Physician profile
Fiona M Lindo
NPI 1962653279
$66,174.18
in general payments reported to CMS, 2019-2025
33 companies · $20K in 2025
The $20K reported for 2025 was more than what 97% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $303 · 2021: $1,536 · 2022: $10K · 2023: $12K · 2024: $8,273 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Consulting Fee: $7,460 · Travel and Lodging: $4,251 · Food and Beverage: $3,460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25,545.00 |
| Consulting Fee | $7,460.00 |
| Travel and Lodging | $4,250.79 |
| Food and Beverage | $3,459.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $37,626.48 | 2021-2025 | Gelpoint V-Path |
| Boston Scientific Corporation | $12,488.12 | 2019-2025 | General - Therapies, Advantage System, Axonics |
| Intuitive Surgical, INC. | $12,196.46 | 2019-2024 | |
| Renovia INC | $722.06 | 2019-2021 | |
| Caldera Medical, INC | $558.92 | 2019-2023 | Desara |
| Astellas Pharma US INC | $441.00 | 2019-2025 | Veozah, Myrbetriq |
| Ethicon US, LLC | $383.10 | 2021-2025 | Evarrest, Stratafix, Dermabond Prineo |
| Medtronic, INC. | $314.36 | 2025 | Ligasure, Signia |
| Coloplast Corp | $203.68 | 2021-2024 | |
| Axonics, INC. | $176.87 | 2021-2023 | Axonics, Bulkamid |
| Pfizer INC. | $161.42 | 2019-2022 | |
| Abbvie INC. | $151.07 | 2020-2025 | |
| Coopersurgical, INC. | $143.85 | 2019 | |
| Allotrope Medical, INC | $96.23 | 2021 | |
| Sumitomo Pharma America, INC. | $70.47 | 2023 | Gemtesa, Myfembree |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bluewind Medical | $41.22 | 2025 | Revi |
| Baxter Healthcare | $40.84 | 2024 | Perclot |
| Octapharma USA, INC. | $39.76 | 2025 | Fibryga |
| Pacira Pharmaceuticals Incorporated | $34.75 | 2020 | |
| Therapeuticsmd, INC. | $28.55 | 2019-2021 | |
| Ambu INC. | $25.93 | 2024 | |
| Femselect INC. | $25.00 | 2024 | Enplace |
| Medical Device Business Services, INC. | $24.39 | 2025 | Enseal |
| Avion Pharmaceuticals | $22.64 | 2023 | Balcoltra |
| Amag Pharmaceuticals, INC. | $21.70 | 2019 | |
| Duchesnay USA Incorporated | $20.91 | 2019 | |
| Dilon Technologies, INC. | $19.69 | 2025 | Hemoblast Bellows |
| Allergan, INC. | $18.93 | 2021 | |
| Lupin INC. | $17.54 | 2019 | |
| Teleflex LLC | $16.11 | 2024 | Solesta |
| Laborie Medical Technologies Corp. | $15.04 | 2020 | |
| Antares Pharma, INC. | $14.30 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $12.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fiona Lindo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.